https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Orforglipron Shows Positive Efficacy, Tolerability in Weight Management

Orforglipron Shows Positive Efficacy, Tolerability in Weight Management

The oral glucagon-like peptide agonist-1 met its primary end point and all secondary end points in a randomized, double-blind, placebo-controlled clinical trial for weight management.

administrator

Related Articles